ANET vs. BBIO
ANET (Arista Networks, Inc.) and BBIO (BridgeBio Pharma, Inc.) are both stocks. ANET operates in Computer Hardware (Technology), while BBIO operates in Biotechnology (Healthcare). Over the past 5 years, ANET returned 47.39%/yr vs 1.89%/yr for BBIO. At a 0.26 correlation, their price movements are largely independent.
Performance
ANET vs. BBIO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ANET achieves a 19.36% return, which is significantly higher than BBIO's -11.92% return.
ANET
- 1D
- 1.38%
- 1M
- 10.32%
- YTD
- 19.36%
- 6M
- 21.14%
- 1Y
- 60.82%
- 3Y*
- 56.72%
- 5Y*
- 47.39%
- 10Y*
- 42.38%
BBIO
- 1D
- -0.35%
- 1M
- -0.03%
- YTD
- -11.92%
- 6M
- -9.25%
- 1Y
- 74.44%
- 3Y*
- 61.48%
- 5Y*
- 1.89%
- 10Y*
- —
ANET vs. BBIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
ANET Arista Networks, Inc. | 19.36% | 18.55% | 87.73% | 94.07% | -15.58% | 97.89% | 42.86% | -21.16% |
BBIO BridgeBio Pharma, Inc. | -11.92% | 178.75% | -32.03% | 429.79% | -54.32% | -76.54% | 102.88% | 27.22% |
Correlation
The correlation between ANET and BBIO is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Jun 28, 2019 | 0.26 |
Fundamentals
ANET:
$199.22B
BBIO:
$13.12B
ANET:
$2.92
BBIO:
-$3.76
ANET:
20.53
BBIO:
23.00
ANET:
$9.71B
BBIO:
$566.04M
ANET:
$6.17B
BBIO:
$538.20M
ANET:
$4.21B
BBIO:
-$602.24M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ANET vs. BBIO — Risk / Return Rank
ANET
BBIO
ANET vs. BBIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Arista Networks, Inc. (ANET) and BridgeBio Pharma, Inc. (BBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ANET | BBIO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.46 | ||
| Sortino ratioReturn per unit of downside risk | -0.53 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.30 | -0.08 |
| Calmar ratioReturn relative to maximum drawdown | 2.16 | 3.70 | -1.54 |
| Martin ratioReturn relative to average drawdown | 4.51 | 9.25 | -4.74 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ANET | BBIO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.15 | 1.60 | -0.46 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.01 | 0.02 | +0.99 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.95 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.83 | 0.16 | +0.66 |
Drawdowns
ANET vs. BBIO - Drawdown Comparison
The maximum ANET drawdown since its inception was -52.20%, smaller than the maximum BBIO drawdown of -92.80%. Use the drawdown chart below to compare losses from any high point for ANET and BBIO.
Loading charts...
Drawdown Indicators
| ANET | BBIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -52.20% | -92.80% | +40.60% |
Max Drawdown (1Y)Largest decline over 1 year | -28.33% | -20.25% | -8.08% |
Max Drawdown (3Y)Largest decline over 3 years | -50.42% | -49.08% | -1.34% |
Max Drawdown (5Y)Largest decline over 5 years | -50.42% | -91.89% | +41.47% |
Max Drawdown (10Y)Largest decline over 10 years | -52.20% | — | — |
Current DrawdownCurrent decline from peak | -12.00% | -15.69% | +3.69% |
Average DrawdownAverage peak-to-trough decline | -15.40% | -45.80% | +30.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.53% | 8.07% | +5.46% |
Volatility
ANET vs. BBIO - Volatility Comparison
Arista Networks, Inc. (ANET) has a higher volatility of 16.83% compared to BridgeBio Pharma, Inc. (BBIO) at 12.10%. This indicates that ANET's price experiences larger fluctuations and is considered to be riskier than BBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ANET | BBIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.83% | 12.10% | +4.73% |
Volatility (6M)Calculated over the trailing 6-month period | 40.41% | 34.41% | +6.00% |
Volatility (1Y)Calculated over the trailing 1-year period | 53.48% | 46.75% | +6.73% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 47.20% | 85.95% | -38.75% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 44.99% | 83.80% | -38.81% |
Dividends
ANET vs. BBIO - Dividend Comparison
Neither ANET nor BBIO has paid dividends to shareholders.
Financials
ANET vs. BBIO - Financials Comparison
This section allows you to compare key financial metrics between Arista Networks, Inc. and BridgeBio Pharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ANET vs. BBIO - Profitability Comparison
ANET - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Arista Networks, Inc. reported a gross profit of 1.68B and revenue of 2.71B. Therefore, the gross margin over that period was 61.9%.
BBIO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, BridgeBio Pharma, Inc. reported a gross profit of 178.39M and revenue of 180.60M. Therefore, the gross margin over that period was 98.8%.
ANET - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Arista Networks, Inc. reported an operating income of 1.16B and revenue of 2.71B, resulting in an operating margin of 42.7%.
BBIO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, BridgeBio Pharma, Inc. reported an operating income of -105.96M and revenue of 180.60M, resulting in an operating margin of -58.7%.
ANET - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Arista Networks, Inc. reported a net income of 1.02B and revenue of 2.71B, resulting in a net margin of 37.8%.
BBIO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, BridgeBio Pharma, Inc. reported a net income of -164.04M and revenue of 180.60M, resulting in a net margin of -90.8%.
Frequently Asked Questions
ANET and BBIO have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ANET has higher volatility (16.83%) compared to BBIO (12.10%). In terms of maximum drawdown, ANET dropped -52.20% vs BBIO's -92.80%.
BBIO currently has the higher Sharpe Ratio (1.60 vs 1.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ANET and BBIO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer